People: Ituran Location and Control Ltd (ITRN.TA)

ITRN.TA on Tel Aviv Stock Exchange

8,156.00
24 Jul 2014
Price Change (% chg)

12.00₪ (+0.15%)
Prev Close
8,121.00₪
Open
8,156.00₪
Day's High
8,156.00₪
Day's Low
8,105.00₪
Volume
3,459
Avg. Vol
22,988
52-wk High
9,009.00₪
52-wk Low
6,151.00₪

Search Stocks

Kahane, Yoav 

Brief Biography

Mr. Yoav Kahane serves as Director of Ituran Location and Control Ltd. since 1998. Currently, Mr. Kahane is serving as Chief Executive Officer (CEO) of Spot-On Therapeutics Ltd., and also provides business development services to other companies. During the years 2006-2009, Mr. Kahane worked for Enzymotec and served as CEO of Advanced Lipids AB, a joint venture of AAK AB and Enzymotec that is specializing in nutritional ingredients to the infant nutrition industry. Prior to that, and during the years 2004-2005, Mr. Kahane served as Vice President of Sales and Marketing in Elbit Vision Systems Ltd. Prior to that date, during the years 2001 and 2002, he served as Manager of Business Development in Denver Holdings and Investments Ltd. In 2000, Mr. Kahane established Ituran Florida Corp. and served as its Chief Executive Officer until 2001. Mr. Kahane has been providing consulting services to the company since 2004. Mr. Kahane holds a B.Sc. degree in Life Sciences form Tel-Aviv University, a B.A. degree in Insurance and an MBA degree from the University of Haifa.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks